Inventor

CHAMBERS MARK STUART

GB46 patents

⚠️ This page may combine multiple inventors who share the name “CHAMBERS MARK STUART”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHAMBERS MARK STUART

MERCK SHARP & DOHME

Imidazo-triazine derivatives as ligands for gaba receptors

Substituted thienlycyclohexanone derivatives for enhancing cognition

Benzodiazepine derivatives

Tetrahydroindolone derivatives as gabaaalpha5 ligands for enhancing cognition

Azetidine, pyrrolidine and piperidine derivatives

Imidazo-triazine derivatives as ligands for GABA receptors

Imidazo-triazine derivatives as ligands for gaba receptors

Imidazo-pyrimidine derivatives as ligands for GABA receptors

Imidazo-pyrimidine derivatives as ligands for gaba receptors

Triazolo-pyrimidine derivatives as ligands for gaba receptors

Tetrahydroindazole derivatives as ligands for GABA-A α 5 receptors

Nitrogen substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives for enhancing cognition

Substituted indolylpropyl-piperazine derivatives as 5-HT1D α agonists

Substituted 1,4-piperazine-heteroaryl derivatives as 5-HT1D receptor agonists

Substituted quinoline-4-carboxylic hydrazides as NK-2/NK-3 receptor ligands

Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition

Pyrazolo[1,5-d][1,2,4] triazines for enhancing cognition

Bicyclic heteroaryl-alkylene-(homo)piperazinones and thione analogues thereof, their preparation, and their use of as selective agonists of 5-HT1 -like receptors

Substituted 1-indolylpropyl-4-benzylpiperazine derivatives

Indoline and azaindoline derivatives as 5-HT1D alpha receptor agonists

Piperazine, piperidine and tetrahydropyridine derivative of indol-3-alkyl as 5-HT1D-α agonists

N-(3-(4-substituted-1-piperidinyl)-1-phenylpropyl) substituted sulfonamides as NK-3 receptor antagonists

Substituted thienobenzisoxazole derivatives for enhancing cognition

Pyrazole derivatives as gamma-secretase inhibitors useful in the treatment of Alzheimer&#39;s disease

Arylsulfonylnaphthalene derivatives as 5HT2A antagonists

ANDREWS MARTIN JAMES INGLIS

Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases

Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases

Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases

Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases

Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases

Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases

MERCK & CO INC

Morpholine and thiomorpholine tachykinin receptor antagonists

Morpholine and thiomorpholine tachykinin receptor antagonists

Morpholine and thiomorpholine tachykinin receptor antagonists

Morpholine and thiomorpholine tachykinin receptor antagonists

Morpholine and thiomorpholine tachykinin receptor antagonists

GALAPAGOS NV

Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases

Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases

Substituted triazolopyrazines useful for the treatment of degenerative and inflammatory diseases

MERCK SHARP & DOME LTD

Piperidine and tetrahydropyridine derivatives

JANSSEN PHARMACEUTICA NV

Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases

MERCK SHARPE & DOHME LTD

Substituted tetralone derivatives for enhancing cognition

CHDI FOUNDATION INC

HTT modulators for treating Huntington&#39;s disease

MERK SHARP & DOHME LTD

5-HT2A receptor ligands

ALMIRALL SA

Amino-substituted heterocyclic derivatives as sodium channel inhibitors

ONO PHARMACEUTICAL CO

Fused imidazole compounds

Pyrazole derivatives as gamma-secretase inhibitors useful in the treatment of Alzheimer's disease

HTT modulators for treating Huntington's disease